2022-2023 2021-2022 2020-2021 2019-2020 2018-2019 2017-2018 2016-2017 2015-2016 2014-2015 2013-2014 2012-2013
 
   
Shareholding Pattern
Omnitex Shareholding Pattern (Clause 31(1)(b)) as at [30.06.2022]
Omnitex Shareholding Pattern (Clause 31(1)(b)) as at [30.09.2022]
Omnitex Shareholding Pattern (Clause 31(1)(b)) as at [31.12.2022]
   
Financial Results
Unaudited Financial Results for the quarter ended 30th June 2022
Unaudited Financial Results for the quarter and half year ended 30th September 2022
Unaudited Financial Results for the quarter and nine months ended on 31st December 2022
   
Other Compliances Disclosure of complaint under regulation 13(3) of SEBI (LODR) Regulation 2015
Disclosure of complaint under regulation 13(3) of SEBI (LODR) Regulation 2015 for the quarter ended June 2022
Disclosure of complaint under regulation 13(3) of SEBI (LODR) Regulation 2015 for the quarter ended September 2022
   
Compliances [Under Regulation. 74(5) of SEBI (Depository & Participant)Regulation,2018]
Compliance Certificate under Regulation 74(5) of the SEBI (D& P) Reglation,2018 for the quarter ended 30th June 2022
Compliance Certificate under Regulation 74(5) of the SEBI (D& P) Reglation,2018 for the quarter ended 30th September 2022
Compliance Certificate under Regulation 74(5) of the SEBI (D& P) Reglation,2018 for the quarter ended 31st December 2022
   
Corporate Governance and Other
Board of Directors
Company Secretary and Compliance Officer
Registrar and Transfer Agent
Registered Office
Corporate Governance Report Under Regulation 27 of SEBI (LODR) Regulation 2018 for the Quarter ended 31st March, 2022
Disclosures of Large Entity Pursuant to SEBI Circular dated November 26, 2018
   
Notices
Notice of Board Meeting to be held on 27th July 2022 to consider and approve Unaudited Financial Results for the quarter ended on 30th June 2022
Notice of Board Meeting to be held on 14th November 2022 to consider and approve Unaudited Financial Results for the quarter ended on 30th September 2022
Notice of Board Meeting to be held on 14th February 2023 to consider and approve Unaudited Financial Results for the quarter ended on 31st December 2022